Rosetta Genomics (Rosetta Genomics) Receivables Turnover : 0.52 (As of Jun. 2017)

View and export this data going back to 2007. Start your Free Trial

What is Rosetta Genomics Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Rosetta Genomics's Revenue for the three months ended in Jun. 2017 was $0.87 Mil. Rosetta Genomics's average Accounts Receivable for the three months ended in Jun. 2017 was $1.66 Mil. Hence, Rosetta Genomics's Receivables Turnover for the three months ended in Jun. 2017 was 0.52.

Rosetta Genomics Receivables Turnover Historical Data

The historical data trend for Rosetta Genomics's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rosetta Genomics Receivables Turnover Chart

Rosetta Genomics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Receivables Turnover

Get a 7-Day Free Trial

4.06

2.60

4.72

4.16

2.85

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
Receivables Turnover	Get a 7-Day Free Trial															0.77	0.12	0.68	0.67	0.52

Competitive Comparison of Rosetta Genomics's Receivables Turnover

For the Diagnostics & Research subindustry, Rosetta Genomics's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics's Receivables Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's Receivables Turnover falls into.

Rosetta Genomics Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Rosetta Genomics's Receivables Turnover for the fiscal year that ended in Dec. 2016 is calculated as

	Receivables Turnover (A: Dec. 2016 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2016 )	/ (	(Accounts Receivable (A: Dec. 2015 )	+	Accounts Receivable (A: Dec. 2016 ))	/	count )
=	9.234	/ (	(3.633	+	2.851)	/	2 )
=	9.234	/	3.242
=	2.85

Rosetta Genomics's Receivables Turnover for the quarter that ended in Jun. 2017 is calculated as

	Receivables Turnover (Q: Jun. 2017 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2017 )	/ (	(Accounts Receivable (Q: Dec. 2016 )	+	Accounts Receivable (Q: Jun. 2017 ))	/	count )
=	0.87	/ (	(2.851	+	0.472)	/	2 )
=	0.87	/	1.6615
=	0.52

Rosetta Genomics (OTCPK:ROSGQ) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Rosetta Genomics Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rosetta Genomics Ltd (OTCPK:ROSGQ) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Plaut Street, Science Park, Rehovot, ISR, 76706

Website

http://www.rosettagenomics.com

Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Executives

Sabby Management, Llc	10 percent owner	115 HIDDEN HILLS DR, SPICEWOOD TX 78669
Sabby Healthcare Volatility Master Fund, Ltd.	10 percent owner	C/O SABBY MANAGEMENT, LLC, 10 MOUNTAINVIEW ROAD, SUITE 205, UPPER SADDLE RIVER NJ 07458

Rosetta Genomics (Rosetta Genomics) Headlines

From GuruFocus

Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

By gurufocus • 12-09-2008